AAPL
64
3
O
26
16
AEE
51
3
WFC
58
8
TRV
34
4
EA
41
3
EXR
42
5
VMC
41
2
CF
47
5
GS
65
16
XRX
48
2
AIV
39
6
LH
33
3
GILD
55
5
KLAC
45
3
SLG
37
6
EMN
40
5
AEP
45
5
PNW
55
3
MMC
46
5
AAPL
64
3
O
26
16
AEE
51
3
WFC
58
8
TRV
34
4
EA
41
3
EXR
42
5
VMC
41
2
CF
47
5
GS
65
16
XRX
48
2
AIV
39
6
LH
33
3
GILD
55
5
KLAC
45
3
SLG
37
6
EMN
40
5
AEP
45
5
PNW
55
3
MMC
46
5
Financhill
Back

Theriva Biologics 10K Form

Sell
27

TOVX
Theriva Biologics

Last Price:
$1.15
Seasonality Move:
27.37%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive TOVX News And Ratings

See the #1 stock for the next 7 days that we like better than TOVX

TOVX Financial Statistics

Sales & Book Value

Annual Sales: $2.6M
Cash Flow: $-3.9M
Price / Cash Flow: 0
Annual Sales: $9.41
Price / Book: 0.13

Profitability

EPS (TTM): -33.18000
Net Income (TTM): $-26.7M
Gross Margin: $0
Return on Equity: 0%
Return on Assets: 0%

Theriva Biologics Earnings Forecast

Key Theriva Biologics Financial Ratios

  • The Selling, General & Administrative Expenses for TOVX have been equal to 80.99% of Gross Profit Margin.
  • The Interest Expense is -0.26% of Operating Income.
  • Per Share Earnings over the last 19 years have been positive in 12 years.

Theriva Biologics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYAM
Industry: Biotechnology
Sector: Health Care
Current Symbol: TOVX
Website: therivabio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 0
Quick Ratio: 0

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

TOVX Technical Analysis vs Fundamental Analysis

Sell
27
Theriva Biologics (TOVX) is a Sell

Is Theriva Biologics a Buy or a Sell?

  • Theriva Biologics stock is rated a Sell
    The current Theriva Biologics [TOVX] share price is $1.14. The Score for TOVX is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.